Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
- PMID: 2832726
- PMCID: PMC363177
- DOI: 10.1128/mcb.8.2.531-539.1988
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
Abstract
The 11-4 p53 cDNA clone failed to transform primary rat fibroblasts when cotransfected with the ras oncogene. Two linker insertion mutations at amino acid 158 or 215 (of 390 amino acids) activated this p53 cDNA for transformation with ras. These mutant cDNAs produced a p53 protein that lacked an epitope, recognized by monoclonal antibody PAb246 (localized at amino acids 88 to 110 in the protein) and preferentially bound to a heat shock protein, hsc70. In rat cells transformed by a genomic p53 clone plus ras, two populations of p53 proteins were detected, PAb246+ and PAb246-, which did or did not bind to this monoclonal antibody, respectively. The PAb246- p53 preferentially associated with hsc70, and this protein had a half-life 4- to 20-fold longer than free p53 (PAb246+). These data suggest a possible functional role for hsc70 in the transformation process. cDNAs for p53 derived from methylcholanthrene-transformed cells transform rat cells in cooperation with the ras oncogene and produce a protein that bound with the heat shock proteins. Recombinant clones produced between a Meth A cDNA and 11-4 were tested for the ability to transform rat cells. A single amino acid substitution at residue 132 was sufficient to activate the 11-4 p53 cDNA for transformation. These studies have identified a region between amino acids 132 and 215 in the p53 protein which, when mutated, can activate the p53 cDNA. These results also call into question what the correct p53 wild-type sequence is and whether a wild-type p53 gene can transform cells in culture.
Similar articles
-
Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.Mol Cell Biol. 1987 Aug;7(8):2863-9. doi: 10.1128/mcb.7.8.2863-2869.1987. Mol Cell Biol. 1987. PMID: 3313006 Free PMC article.
-
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.J Virol. 1989 Feb;63(2):739-46. doi: 10.1128/JVI.63.2.739-746.1989. J Virol. 1989. PMID: 2642977 Free PMC article.
-
Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.J Virol. 1986 Sep;59(3):574-83. doi: 10.1128/JVI.59.3.574-583.1986. J Virol. 1986. PMID: 3016321 Free PMC article.
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.Am J Gastroenterol. 1993 Feb;88(2):174-86. Am J Gastroenterol. 1993. PMID: 8424417 Review.
Cited by
-
Negative regulation of Rb expression by the p53 gene product.Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5206-10. doi: 10.1073/pnas.89.12.5206. Proc Natl Acad Sci U S A. 1992. PMID: 1608930 Free PMC article.
-
Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.Nucleic Acids Res. 1992 Jul 11;20(13):3435-41. doi: 10.1093/nar/20.13.3435. Nucleic Acids Res. 1992. PMID: 1630914 Free PMC article.
-
Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation.Mol Cell Biol. 1991 Jul;11(7):3472-83. doi: 10.1128/mcb.11.7.3472-3483.1991. Mol Cell Biol. 1991. PMID: 1646391 Free PMC article.
-
Mutation of the serine 312 phosphorylation site does not alter the ability of mouse p53 to inhibit simian virus 40 DNA replication in vivo.J Virol. 1990 Apr;64(4):1734-44. doi: 10.1128/JVI.64.4.1734-1744.1990. J Virol. 1990. PMID: 2157055 Free PMC article.
-
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.EMBO J. 1990 May;9(5):1595-602. doi: 10.1002/j.1460-2075.1990.tb08279.x. EMBO J. 1990. PMID: 1691710 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous